Jonakayem Pharma Formulation (OPC) Pvt. Ltd.
DORZOLAMIDE

DORZOLAMIDE

Send Inquiry

DORZOLAMIDE

Sub Group Generic Formulations Brand name Dosages Unit In treatment of Adverse Effects Contraiindication Special Precaution Interaction Servings

DORZOLAMIDE Trusopt 2% 5 ML EYE DPS Oculat HTN;Open angle Glaucoma 1. Bitter taste
2. Ocular burning and stinging
3. Conjunctivitis
4. Eye lid irritations
5. Nausea
6. Fatigue
7. Blurred vision
8. Lacrimation
9. Paresthesia
10. Urolithiasis
11. Dizziness
12. Corneal Oedema
13. Hypersensitivity reactions
14. Rhinitis
15. Sinusitis
16. Asthenia
17. Epistaxis
18. Angioedema
19. Ototoxicity
1. Hypersensitivity to the drug
2. Renal impairment
3. Hyperchloremic acidosis

1. Hepatic impairment
2. Avoid use together with other carbonic anhydrase inhibitors
3. Discontinue the drug in hypersensitivity reactions
4. Stop the drug in corneal oedema, conjunctivitis, and eye lid reactions
5. Intraocular surgery
6. Corneal defects
7. Urolithiasis
Similar to diuretics (carbonic anhydrase inhibitor) – as possibility of systemic absorption after topical administration.
One drop of 2% solution three times daily.